INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Nagao Hideki reported MNOV

Director · MEDICINOVA INC · MEDICINOVA INC — Stock Option (Right to Buy)

Side
A
Value
—
Shares
44.5K
Price
—
Executed
Jun 23, 2026
Disclosed
Jun 25, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 23 executedJun 25, 2026 disclosed

MNOV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MNOV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    LN
    Lemerond NicoleDirector
    MNOVMEDICINOVA INC
    Grant or award
    A—
    44.5K sh
    Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    +2dSEC FORM 4

    Evidence

    9
    BC
    Beaver CarolynDirector
    MNOVMEDICINOVA INC
    Grant or award
    A—
    44.5K sh
    Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001683168-26-005111
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 23, 2026
    Published
    Jun 25, 2026
    Ingested by INSIDER
    Nov 5, 03:51 UTC
    Last re-read
    Nov 5, 03:51 UTC

    Extracted facts

    Filer
    Nagao Hideki
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    MEDICINOVA INC — Stock Option (Right to Buy)
    Ticker
    MNOV
    Shares
    44.5K
    Price per share
    $0
    Execution date (reported)
    Jun 23, 2026
    Owned after transaction
    44.5K shares
    Days from execution to publication
    2

    What this establishes

    Nagao Hideki filed this Form 4 reporting a grant or award of MNOV on Jun 23, 2026. It became public on Jun 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Nagao Hidekicik:0001315306
    Issuer
    MEDICINOVA INCcik:0001226616

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.